Shilpa Medicare Ltd Receives EU GMP Status From Austrian Authority

Shilpa Medicare Ltd’s Finished Dosage Formulation Facility (Sterile and Non-sterile) located at S-20 to S-26, Pharmaceutical Formulations SEZ, TSIIC, Jadcherla, Telangana State, India has been issued EU GMP by Austrian Authority (AGES) for the inspection held during 13 to 17 Jan 2020. Shilpa Medicare Limited’s affiliates have registered it’s products (Oral solids & Injections) with European authorities for commercial distribution. The renewed EU GMP facilitates continued supply of products to European union.

Shares of SHILPA MEDICARE LTD. was last trading in BSE at Rs.256.7 as compared to the previous close of Rs. 244.5. The total number of shares traded during the day was 2556 in over 298 trades.

The stock hit an intraday high of Rs. 256.7 and intraday low of 251. The net turnover during the day was Rs. 653050.-Equity Bulls